Phosphoinositide and redox dysregulation by the anticancer methylthioadenosine phosphorylase transition state inhibitor

• Published in: Biochimica et biophysica acta. Molecular and cell biology of lipids 2023-09, Vol.1868 (9), p.159346-159346, Article 159346
• Main Authors: Salita, Timothy, Rustam, Yepy H., Hofferek, Vinzenz, Jackson, Michael, Tollestrup, Isaac, Sheridan, Jeffrey P., Schramm, Vern L., Evans, Gary B., Reid, Gavin E., Munkacsi, Andrew B.
• Format: Article
• Language: English
• Subjects: biosynthesis; Cancer therapeutics; cancer therapy; cell biology; genes; growth and development; homeostasis; immune response; interleukin-10; Lipid metabolism; Lipidomics; lipids; mammals; Mass spectrometry; metabolites; nitric oxide; Phosphoinositide; phosphorylase; polyamines; reactive oxygen species; S-adenosylmethionine; Saccharomyces cerevisiae; toxicity; Transition-state analog; tumor necrosis factor-alpha; yeasts
• ISSN: 1388-1981; 1879-2618
• DOI: 10.1016/j.bbalip.2023.159346

Methylthio-DADMe-immucillin-A (MTDIA) is an 86 picomolar inhibitor of 5′-methylthioadenosine phosphorylase (MTAP) with potent and specific anti-cancer efficacy. MTAP salvages S-adenosylmethionine (SAM) from 5′-methylthioadenosine (MTA), a toxic metabolite produced during polyamine biosynthesis. Changes in MTAP expression are implicated in cancer growth and development, making MTAP an appealing target for anti-cancer therapeutics. Since SAM is involved in lipid metabolism, we hypothesised that MTDIA alters the lipidomes of MTDIA-treated cells. To identify these effects, we analysed the lipid profiles of MTDIA-treated Saccharomyces cerevisiae using ultra-high resolution accurate mass spectrometry (UHRAMS). MTAP inhibition by MTDIA, and knockout of the Meu1 gene that encodes for MTAP in yeast, caused global lipidomic changes and differential abundance of lipids involved in cell signaling. The phosphoinositide kinase/phosphatase signaling network was specifically impaired upon MTDIA treatment, and was independently validated and further characterised via altered localization of proteins integral to this network. Functional consequences of dysregulated lipid metabolism included a decrease in reactive oxygen species (ROS) levels induced by MTDIA that was contemporaneous with changes in immunological response factors (nitric oxide, tumour necrosis factor-alpha and interleukin-10) in mammalian cells. These results indicate that lipid homeostasis alterations and concomitant downstream effects may be associated with MTDIA mechanistic efficacy.